Human Leukocyte Antigen Testing Market Global Report 2021, 28

Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Services (Reagents & Consumables, Instruments, and Software & Services), Technology [Molecular Assay Technologies (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, and Others) and Non-Molecular Assay Technologies], and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others), and Geography

Publication Month : May 2022

  • Report Code : TIPRE00021578
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 221
Inquire Before Buy

PRICING

$4550

$3640

The human leukocyte antigen (HLA) testing market is projected to reach US$ 1,155.65 million by 2028 from US$ 697.74 million in 2021; it is expected to register a CAGR of 7.5% from 2022 to 2028.   

Human leukocyte antigens play an essential part in the body's immune response to external substances. The principal use for HLA testing is to match organ and tissue transplant recipients with compatible donors. The HLA testing also involves screening transplant recipients for the presence of antibodies that might target the donated tissue or organ as part of an immune response.    

The report offers insights and in-depth analysis of the human leukocyte antigen (HLA) testing market emphasizing market trends, technological advancements, and market dynamics, among others. It also provides the competitive landscape analysis of the globally leading market players. Furthermore, it includes the impact of the COVID-19 pandemic on the market across all the major regions. The COVID-19 pandemic created both a public health crisis and an economic crisis worldwide. Before the pandemic, the human leukocyte antigen (HLA) testing market was growing continuously owing to the regularity in the assessment of organ donors, consolations, and treatments. The first wave of COVID-19 disrupted the consultations, follow-ups, and screenings related to diseases other than COVID-19. Several companies experienced severe losses in the last quarter of 2019; the pandemic particularly had adverse effects on the global market in the first and second quarters of 2020. Businesses worldwide were hampered due to disruption in supply chains, and increased demand for healthcare products and services. To reduce COVID-19 infection in hospitals and clinics, healthcare practitioners and patients adopted and preferred treating their patients remotely. These unforeseeable circumstances also hampered organ transplantation procedures. Many surgical treatments and non-urgent consultations were canceled or postponed, and elective surgeries were suspended in many institutions to limit the spread of SARS-CoV-2 as well as to reserve and reallocate resources, including healthcare personnel (nurses and anesthesiologists), medical equipment (personal protective equipment and ventilators), and beds. The "stay at home" recommendation resulted in a significant reduction in organ donation and organ transplantation surgeries. These conditions restrained the growth of the human leukocyte antigen (HLA) testing market worldwide in 2020.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Human Leukocyte Antigen (HLA) Testing Market: Strategic Insights

human-leukocyte-antigen-hla-testing-market
Market Size Value inUS$ 697.74 Million in 2021
Market Size Value byUS$ 1,155.65 Million by 2028
Growth rateCAGR of 7.5% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Lucrative Regions for human leukocyte antigen (HLA) testing market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights
Increasing Number of Plasma Donation and Organ Transplantation Procedures Drive Market Growth

Human leukocyte antigens (HLAs) are the specialized proteins present on all cell surfaces of the human body, except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice worldwide. According to data published in Global Observatory on Donation and Transplantation (GODT), in 2020, 129,681 organ transplants were recorded in total. Of these, 31.7% were living kidney transplants and 20.40% were living liver transplants.

Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. For Instance, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplantation procedures in the US. These strategies focus on increasing the number of organ and tissue transplants among patients with end-stage organ disease, altering the current organ distribution, and modifying organ transplantation waitlist by redistributing the existing organ soppy. Furthermore, the OPTN has used out-of-box strategies to improve organ transplantation. These innovative strategies include the optimized use of organs obtained from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], reducing discards of organs, promoting living donation, and improving the rate of potential organ donation authorization. 

Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the growth of the HLA testing market.

Product and Services-Based Insights              

Based on product and services, the human leukocyte antigen (HLA) testing market is segmented into reagents and consumables, instruments, and software and services. In 2021, the reagents and consumables segment held the largest share of the market, and it is expected to register the fastest CAGR of 7.5% during the forecast period.   

Human leukocyte antigen (HLA) testing market, by Product and Services – 2022 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Technology-Based Insights

Based on technology, the human leukocyte antigen (HLA) testing market is segmented into molecular assay technologies and non-molecular assay technologies. In 2021, the molecular assay technologies segment held a largest share of the market, and it is expected to record a higher CAGR of 7.7% during 2022–2028.

End User-Based Insights

Based on end user, the human leukocyte antigen (HLA) testing market is segmented into independent reference laboratories, hospitals and transplant centers, and others. In 2021, the independent reference laboratories segment held the largest share of the market. However, hospitals and transplant centers segment is expected to report the highest CAGR of 7.9% during 2022–2028

The human leukocyte antigen (HLA) testing market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide, along with meeting the growing product demands.

By Geography

Based on geography, the human leukocyte antigen (HLA) testing market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Company Profiles

  • Thermo Fisher Scientific Inc.
  • CareDx
  • Qiagen
  • Illumina Inc.
  • Bio-Rad Laboratories, Inc.
  • TBG Diagnostics Limited
  • F.Hoffmann-La Roche Ltd.
  • Takara Bio Inc.
  • Luminex Corporation
  • Omixon Inc.
  • The Sequencing Center
  • Protrans
  • HistoGenetics LLC.
  • CD Genomics
  • Qunitara Biosciences
  • CeGat GmbH
  • Creative Biolabs Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product and Services, Technology, and End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is meant by the human leukocyte antigen (HLA) testing market?

Human leukocyte antigens play an essential part in the body's immune response to external substances. The principal use for human leukocyte antigen (HLA) testing is to match organ and tissue transplant recipients with compatible donors. HLA testing also involves screening transplant recipients for the presence of antibodies that might target the donated tissue or organ as part of an immune response.

What are the driving factors for the human leukocyte antigen (HLA) testing market across the globe?

Increasing plasma donation and organ transplants procedures is one of the most significant factors responsible for the overall market growth.

Which segment led the human leukocyte antigen (HLA) testing market?

Based on product and service type, reagent and consumables took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which technology segment held the largest revenue (US$ Mn) in the human leukocyte antigen (HLA) testing market?

The molecular assay technologies segment dominated the global human leukocyte antigen (HLA) testing market and is likely to account for the revenue of US$ 626.86 million in 2022.

Who are the key players in the human leukocyte antigen (HLA) testing market?

Thermo Fisher Scientific, Inc., CareDx, Inc., Qiagen N.V., Illumina, Bio-Rad Laboratories, Inc., TGB Diagnostics Ltd., F. Hoffman La-Roche Ltd., Takara Bio, Luminex Corporation, Oximon, The Sequencing Center, Protrans, HistoGenetics LLC, CD Genomics, Quintara Biosciences, CeGaT GmbH, Creative Biolabs, Inc., are among the leading companies operating in the global human leukocyte antigen (HLA) testing market

What is the regional market scenario of the human leukocyte antigen (HLA) testing market?

Global human leukocyte antigen (HLA) testing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for human leukocyte antigen (HLA) testing market. The US is estimated to hold the largest share in the human leukocyte antigen (HLA) testing market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia-Pacific regional growth for human leukocyte antigen (HLA) testing accounting fastest growth of the region during the coming years.

The List of Companies - Human Leukocyte Antigen (HLA) Market

  1. Thermo Fisher Scientific Inc.
  2. CareDx
  3. Qiagen
  4. Illumina Inc.
  5. Bio-Rad Laboratories, Inc.
  6. TBG Diagnostics Limited
  7. F.Hoffmann-La Roche Ltd.
  8. Takara Bio Inc.
  9. Luminex Corporation
  10. Omixon Inc.
  11. The Sequencing Center
  12. Protrans
  13. HistoGenetics LLC.
  14. CD Genomics
  15. Qunitara Biosciences
  16. CeGat GmbH
  17. Creative Biolabs Inc.   

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Human Leukocyte Antigen (HLA) Testing Market